Interpretation of guidelines for the diagnosis and treatment of primary liver cancer （2026 edition）
- VernacularTitle:《原发性肝癌诊疗指南（2026年版）》解读
- Author:
Yanbin NI
1
;
Jiye ZHU
1
;
Zhao LI
1
Author Information
- Publication Type:Journal Article
- Keywords: Liver Neoplasms; Diagnosis; Therapeutics; Practice Guidelines as Topic
- From: Journal of Clinical Hepatology 2026;42(7):1572-1575
- CountryChina
- Language:Chinese
- Abstract: In April 2026， the National Health Commission of the People’s Republic of China released Guidelines for the diagnosis and treatment of primary liver cancer （2026 edition）. This edition incorporates an independent chapter of “prevention， screening， and monitoring” to build a hierarchical and precise prevention and control system， establishes a comprehensive therapeutic paradigm targeting surgical resection， and clarifies the core position of conversion therapy and neoadjuvant therapy. It also updates the recommendations for interventional and systemic therapies and strengthens the whole-course management of underlying liver diseases. This article interprets the key updates of this new edition to better guide clinical practice.
